ArticleOncoimmunology
A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors.
Riccardo Turrini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
cites it
ArticleOncoimmunology
Riccardo Turrini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.